N@N

Oculus Innovative Sciences Inc (NASDAQ:OCLS), Up By 83.75% ($1.58) After BUYINS.NET SqueezeTrigger Report Released on Monday, A

^{Published on 2013-04-02 07:47:20 - WOPRAI}
 

April 2, 2013 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, released a report on Monday, April 1st 2013 at 05:16:00 PDT stating that Oculus Innovative Sciences Inc (NASDAQ:OCLS) was expected to be Up After it crossed above its SqueezeTrigger Price of 1.88 on Monday, April 1st 2013. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=ocls&id=357760

From August 2009 to March 2013, an aggregate amount of 36339559 shares of OCLS have been shorted for a total dollar value of $36339559. The OCLS SqueezeTrigger price of $1.88 is the volume weighted average price that all shorts are short in shares of OCLS. There is still approximately $500,280 of potential short covering in shares of OCLS.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger Price for each stock that has been shorted. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of short squeeze events. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com .

Oculus Innovative Sciences Inc (NASDAQ:OCLS) - Oculus Innovative Sciences, Inc. designs, produces, and markets drugs, devices, and nutritional products based on its Microcyn platform technology for the dermatology, surgical, wound care, and animal healthcare markets in the United States, Mexico, Europe, and internationally. Microcyn platform technology is based on electrically charged oxychlorine small molecules that target a range of disease causing organisms, which include viruses, fungi, spores, and antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in wounds, as well as Clostridium difficile, a highly contagious bacteria spread by human contact. It offers Microcyn-based human wound and skin care products as prescription and over-the-counter products; and Microcyn technology-based animal healthcare products under the Vetericyn brand name. The company also offers Glucorein Green Tea with chlorogenic acid, a medical food for the dietary management of glucose levels in pre-diabetics and type 2 diabetics. Its Microcyn has received seven 510(k) clearances for use as a medical device in wound care management, including for acute and chronic wounds, and in dermatology applications. In addition, the company provides consulting and laboratory services to medical companies that design and manufacture biomedical devices and drugs. It sells its products to hospitals, physicians, nurses, and other healthcare practitioners who are the primary caregivers to patients being treated for acute or chronic wounds or undergoing surgical procedures, as well as to dermatologists for the treatment of various skin afflictions. Oculus sells its products directly, as well as through contract sales organization and distributors. The company was formerly known as Micromed Laboratories, Inc. and changed its name to Oculus Innovative Sciences, Inc. in August 2001. Oculus Innovative Sciences, Inc. was incorporated in 1999 and is based in Petaluma, California..

The SqueezeTrigger database of approximately 1 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net